[{"address1": "700 Quince Orchard Road", "city": "Gaithersburg", "state": "MD", "zip": "20878", "country": "United States", "phone": "240 268 2000", "website": "https://www.novavax.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.", "fullTimeEmployees": 952, "companyOfficers": [{"maxAge": 1, "name": "Mr. John Charles Jacobs M.B.A.", "age": 57, "title": "President, CEO & Director", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 1550611, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James Patrick Kelly C.F.A.", "age": 58, "title": "Executive VP, CFO & Treasurer", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 880849, "exercisedValue": 0, "unexercisedValue": 19825}, {"maxAge": 1, "name": "Mr. Mark J. Casey Esq.", "age": 61, "title": "Executive VP, Chief Legal Officer & Corporate Secretary", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 997654, "exercisedValue": 0, "unexercisedValue": 89347}, {"maxAge": 1, "name": "Ms. Elaine  O'Hara", "age": 56, "title": "Executive VP & Chief Strategy Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 991316, "exercisedValue": 0, "unexercisedValue": 35053}, {"maxAge": 1, "name": "Mr. Richard P. Crowley", "age": 67, "title": "Executive VP & COO", "yearBorn": 1957, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Troy  Morgan Esq., J.D.", "age": 53, "title": "Senior VP, Deputy General Counsel & Chief Compliance Officer", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Erika S. Trahan", "title": "Associate Director of Investor & Public Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ian J. Watkins", "age": 61, "title": "Executive VP & Chief Human Resources Officer", "yearBorn": 1963, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Silvia  Taylor M.B.A.", "title": "Executive VP and Chief Corporate Affairs & Advocacy Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Henrietta  Ukwu FACP FRAPS, M.D.", "age": 57, "title": "Executive VP & Chief Regulatory Officer", "yearBorn": 1967, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 5, "compensationRisk": 6, "shareHolderRightsRisk": 5, "overallRisk": 5, "governanceEpochDate": 1759276800, "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://www.novavax.com/go.cfm?do=Stock.GetQuote", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 8.36, "open": 8.59, "dayLow": 8.425, "dayHigh": 8.65, "regularMarketPreviousClose": 8.36, "regularMarketOpen": 8.59, "regularMarketDayLow": 8.425, "regularMarketDayHigh": 8.65, "payoutRatio": 0.0, "beta": 2.746, "trailingPE": 3.837838, "forwardPE": -53.250004, "volume": 2743364, "regularMarketVolume": 2743364, "averageVolume": 6151085, "averageVolume10days": 4686400, "averageDailyVolume10Day": 4686400, "bid": 8.4, "ask": 8.54, "bidSize": 7, "askSize": 11, "marketCap": 1383832576, "fiftyTwoWeekLow": 5.01, "fiftyTwoWeekHigh": 11.55, "allTimeHigh": 331.68, "allTimeLow": 3.53, "priceToSalesTrailing12Months": 1.2828493, "fiftyDayAverage": 8.443, "twoHundredDayAverage": 7.6248, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1000018432, "profitMargins": 0.39196998, "floatShares": 136489405, "sharesOutstanding": 162421645, "sharesShort": 45828036, "sharesShortPriorMonth": 44723391, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.28219998, "heldPercentInsiders": 0.08748, "heldPercentInstitutions": 0.5858, "shortRatio": 10.03, "shortPercentOfFloat": 0.2832, "impliedSharesOutstanding": 162421645, "bookValue": 0.232, "priceToBook": 36.72414, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "earningsQuarterlyGrowth": -0.344, "netIncomeToCommon": 422824000, "trailingEps": 2.22, "forwardEps": -0.16, "lastSplitFactor": "1:20", "lastSplitDate": 1557446400, "enterpriseToRevenue": 0.927, "enterpriseToEbitda": 2.454, "52WeekChange": -0.1687805, "SandP52WeekChange": 0.16625166, "quoteType": "EQUITY", "currentPrice": 8.52, "targetHighPrice": 25.0, "targetLowPrice": 6.0, "targetMeanPrice": 13.21111, "targetMedianPrice": 10.9, "recommendationMean": 2.44444, "recommendationKey": "buy", "numberOfAnalystOpinions": 9, "totalCash": 612304000, "totalCashPerShare": 3.77, "ebitda": 407505984, "totalDebt": 228490000, "quickRatio": 2.155, "currentRatio": 2.363, "totalRevenue": 1078717952, "debtToEquity": 607.282, "revenuePerShare": 6.705, "returnOnAssets": 0.14515, "grossProfits": 616860992, "freeCashflow": -627235008, "operatingCashflow": -630940992, "earningsGrowth": -0.381, "revenueGrowth": -0.424, "grossMargins": 0.57185, "ebitdaMargins": 0.37777, "operatingMargins": 0.44169, "financialCurrency": "USD", "symbol": "NVAX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 818173800000, "exchange": "NMS", "messageBoardId": "finmb_350381", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 1.91389, "regularMarketPrice": 8.52, "fiftyDayAverageChange": 0.07700062, "fiftyDayAverageChangePercent": 0.009120055, "twoHundredDayAverageChange": 0.89520025, "twoHundredDayAverageChangePercent": 0.11740639, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.4 - Buy", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1761350371, "regularMarketTime": 1761336000, "marketState": "CLOSED", "shortName": "Novavax, Inc.", "longName": "Novavax, Inc.", "postMarketChangePercent": -0.352121, "postMarketPrice": 8.49, "postMarketChange": -0.0300007, "regularMarketChange": 0.160001, "regularMarketDayRange": "8.425 - 8.65", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 6151085, "fiftyTwoWeekLowChange": 3.5100002, "fiftyTwoWeekLowChangePercent": 0.70059884, "fiftyTwoWeekRange": "5.01 - 11.55", "fiftyTwoWeekHighChange": -3.0299997, "fiftyTwoWeekHighChangePercent": -0.26233763, "fiftyTwoWeekChangePercent": -16.87805, "dividendDate": 1557446400, "earningsTimestamp": 1754483400, "earningsTimestampStart": 1762777800, "earningsTimestampEnd": 1762777800, "earningsCallTimestampStart": 1754483400, "earningsCallTimestampEnd": 1754483400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": 2.22, "epsForward": -0.16, "epsCurrentYear": 2.21938, "priceEpsCurrentYear": 3.8389103, "displayName": "Novavax", "trailingPegRatio": null, "__fetch_time": "2025-10-25"}]